Cure My Disease

Don't miss your cure!

 Log in / Sign up

Scientists hunt for biomarkers to catch pancreatic cancer before it strikes

NCT ID NCT07709052

Not yet recruiting Diagnosis Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis Source: ClinicalTrials.gov ↗

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study aims to find molecular clues that could predict whether certain pancreatic growths will turn into cancer. Researchers will analyze tissue from patients having pancreatic surgery, using advanced genetic and protein tests on both the original tissue and lab-grown 3D cell models. The goal is to improve early detection and risk assessment for pancreatic ductal adenocarcinoma, a cancer that is often diagnosed too late.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a test that identifies which patients with pancreatic cysts or precancerous changes are at high risk of developing pancreatic cancer, enabling earlier intervention.
What could go wrong
This is an observational study, not a treatment trial. The biomarkers identified may not prove accurate enough for clinical use, and results from lab-grown tumor models may not reflect real patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF PANCREAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intraepithelial neoplasia pancreatic ductal adenocarcinoma Pancreatic Intraductal Neoplasms pancreatic intraductal papillary-mucinous neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF PANCREAS PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) PANCREATIC INTRAEPITHELIAL NEOPLASIA

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.